Harlequin Syndrome during Venoarterial Extracorporeal Membrane Oxygenation.
作者信息
Pasrija Chetan, Bedeir Kareem, Jeudy Jean, Kon Zachary N
机构信息
Division of Cardiac Surgery (C.P.) and Department of Radiology (J.J.), University of Maryland, 110 S Paca St, 7th Floor, Baltimore, MD 21201; Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, Mass (K.B.); and New York University, Department of Cardiothoracic Surgery, New York, NY (Z.N.K.).
出版信息
Radiol Cardiothorac Imaging. 2019 Jun 20;1(2):e190031. doi: 10.1148/ryct.2019190031. eCollection 2019 Jun.
Abstract
摘要
相似文献
1
Harlequin Syndrome during Venoarterial Extracorporeal Membrane Oxygenation.静脉-动脉体外膜肺氧合期间的小丑综合征
Radiol Cardiothorac Imaging. 2019 Jun 20;1(2):e190031. doi: 10.1148/ryct.2019190031. eCollection 2019 Jun.
2
Cross-Field Ventilation for Treatment of Harlequin Syndrome in Traumatic Tracheobronchial Injury Repair Using Intraoperative Venoarterial Extracorporeal Membrane Oxygenation.术中静脉-动脉体外膜肺氧合辅助下跨肺通气在创伤性气管支气管损伤修复中治疗丑角综合征的应用
J Cardiothorac Vasc Anesth. 2019 Nov;33(11):3090-3094. doi: 10.1053/j.jvca.2019.03.033. Epub 2019 Mar 18.
3
Risk factors for critical limb ischemia in patients undergoing femoral cannulation for venoarterial extracorporeal membrane oxygenation: Is distal limb perfusion a mandatory approach?接受股动脉插管进行静脉-动脉体外膜肺氧合治疗的患者发生严重肢体缺血的危险因素：远端肢体灌注是一种必要的方法吗？
Perfusion. 2019 Sep;34(6):453-459. doi: 10.1177/0267659119827231. Epub 2019 Feb 8.
4
Pulmonary artery pressure may be a predictor of closed aortic valve in patients managed by venoarterial extracorporeal membrane oxygenation.肺动脉压可能是接受静脉-动脉体外膜肺氧合治疗患者主动脉瓣关闭不全的预测因子。
Int J Artif Organs. 2020 Sep;43(9):594-599. doi: 10.1177/0391398820901841. Epub 2020 Jan 31.
5
Developing a standard method for apnea testing in the determination of brain death for patients on venoarterial extracorporeal membrane oxygenation: a pediatric case series.在使用体外膜肺氧合（VA-ECMO）治疗的患者中，开发一种用于确定脑死亡的呼吸暂停测试的标准方法：一项儿科病例系列研究。
Pediatr Crit Care Med. 2014 Feb;15(2):e38-43. doi: 10.1097/PCC.0000000000000006.
6
Venoarterial extracorporeal membrane oxygenation support for refractory cardiovascular dysfunction during severe bacterial septic shock.严重细菌性脓毒症休克时难治性心血管功能障碍的静脉动脉体外膜氧合支持。
Crit Care Med. 2013 Jul;41(7):1616-26. doi: 10.1097/CCM.0b013e31828a2370.
7
The Effect of Intraaortic Balloon Pumping Under Venoarterial Extracorporeal Membrane Oxygenation on Mortality of Cardiogenic Patients: An Analysis Using a Nationwide Inpatient Database.主动脉内球囊反搏在静脉-动脉体外膜肺氧合下对心源性病患死亡率的影响：利用全国住院患者数据库进行的分析。
Crit Care Med. 2016 Nov;44(11):1974-1979. doi: 10.1097/CCM.0000000000001828.
8
Venoarterial Extracorporeal Membrane Oxygenation Versus Conventional Therapy in Severe Pediatric Septic Shock.脉动脉体外膜肺氧合与常规疗法治疗小儿严重脓毒性休克的比较。
Pediatr Crit Care Med. 2018 Oct;19(10):965-972. doi: 10.1097/PCC.0000000000001660.
9
Venoarterial extracorporeal membrane oxygenation for postcardiotomy shock: Risk factors for mortality.体外膜肺氧合在心脏手术后休克中的应用：死亡率的危险因素。
J Thorac Cardiovasc Surg. 2018 Nov;156(5):1894-1902.e3. doi: 10.1016/j.jtcvs.2018.05.061. Epub 2018 Jun 4.
10
Cardiac Arrest Prior to Venoarterial Extracorporeal Membrane Oxygenation: Risk Factors for Mortality.心肺复苏前应用体外膜肺氧合治疗的危险因素：死亡率。
Crit Care Med. 2019 Jul;47(7):926-933. doi: 10.1097/CCM.0000000000003772.
引用本文的文献
1
Six-Year Single-Center Experience with ECMO Use in Various Strategies for Lung Transplantation, Including COVID-19 Patients.在包括新冠肺炎患者在内的各种肺移植策略中使用体外膜肺氧合（ECMO）的六年单中心经验。
J Clin Med. 2025 Jun 12;14(12):4195. doi: 10.3390/jcm14124195.
2
Harlequin syndrome in a young patient with osteosarcoma after pleural metastasectomy: A case report and a mini review of the literature.一名骨肉瘤青年患者行胸膜转移瘤切除术后发生丑角综合征：一例报告并文献综述
Exp Ther Med. 2025 Jan 30;29(4):62. doi: 10.3892/etm.2025.12812. eCollection 2025 Apr.
3
Effect of upper body venoarterial ECMO on systemic hemodynamics and oxygenation: A computational study.上半身静脉动脉体外膜肺氧合对全身血液动力学和氧合的影响：一项计算研究。
Comput Biol Med. 2024 Nov;182:109124. doi: 10.1016/j.compbiomed.2024.109124. Epub 2024 Sep 13.
4
Extra-Corporeal Membrane Oxygenation in Pregnancy.孕期体外膜肺氧合
J Clin Med. 2024 Mar 13;13(6):1634. doi: 10.3390/jcm13061634.
5
Pharmacological Considerations during Percutaneous Treatment of Heart Failure.心力衰竭经皮治疗的药理学考虑。
Curr Pharm Des. 2024;30(8):565-577. doi: 10.2174/0113816128284131240209113009.
6
Trends on Near-Infrared Spectroscopy Associated With Acute Brain Injury in Venoarterial Extracorporeal Membrane Oxygenation.经静脉-动脉体外膜肺氧合治疗的急性脑损伤与近红外光谱相关的趋势。
ASAIO J. 2023 Dec 1;69(12):1083-1089. doi: 10.1097/MAT.0000000000002032. Epub 2023 Aug 9.
7
Central extracorporeal circulatory life support (cECLS) in selected patients with critical cardiogenic shock.对部分重症心源性休克患者实施体外循环生命支持（cECLS）。
Front Cardiovasc Med. 2023 Apr 17;10:1142953. doi: 10.3389/fcvm.2023.1142953. eCollection 2023.
8
Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: a bicenter retrospective propensity score-weighted analysis.在接受体外膜肺氧合（VA-ECMO）治疗难治性心源性休克的患者中，早期高氧血症与 28 天死亡率的关系：一项基于双中心回顾性倾向评分加权分析。
Crit Care. 2022 Aug 26;26(1):257. doi: 10.1186/s13054-022-04133-7.
Zotero 插件